Bevacizumab

In the US, Bevacizumab (bevacizumab systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic, Colorectal Cancer, Glioblastoma Multiforme, Macular Degeneration, Malignant Glioma, Neurofibromatosis, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Renal Cell Carcinoma and Solid Tumors.

US matches:

• Bevacizumab Solution


• Bevacizumab


• Bevacizumab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC07

CAS registry number (Chemical Abstracts Service)

0216974-75-3

Chemical Formula

C6638-H10160-N1720-O2108-S44

Molecular Weight

149197

Therapeutic Categories

Antineoplastic agent

Monoclonal antibody

Angiogenesis inhibitor

Chemical Name

Immunoglobulin G1 (human-mouse monoclonal rhuMAb-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMab-VEGF light chain, dimer (WHO)

Foreign Names

• Bevacizumabum (Latin)
• Bevacizumab (German)
• Bévacizumab (French)
• Bevacizumab (Spanish)

Generic Names

• Bevacizumab (OS: USAN)
• anti-VEGF Mab (IS)
• Anti-VEGF monoclonal antibody (IS)
• rhuMAb-VEGF (IS)
• VEGF light chain, dimer (IS: WHO)

Brand Names

• Altuzan
  Roche, Turkey



• Avastatin
  Roche, Ecuador



• Avastin
  Genentech, United States; Roche, United Arab Emirates; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Bulgaria; Roche, Bahrain; Roche, Canada; Roche, Switzerland; Roche, Chile; Roche, Colombia; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Georgia; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, Iraq; Roche, Iran; Roche, Iceland; Roche, Italy; Roche, Jordan; Roche, Kuwait; Roche, Lebanon; Roche, Luxembourg; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Portugal; Roche, Qatar; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Sweden; Roche, Singapore; Roche, Slovenia; Roche, Slovakia; Roche, Syria; Roche, Thailand; Roche, Taiwan; Roche, Venezuela; Roche, Yemen; Roche, South Africa; Roche Diagnostic, Algeria

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.